PSB 2016 - Jennifer Doudna: CRISPR Biology, A New Era in Genome Engineering

Jennifer Doudna presents brief history of CRISPR-Cas9 biology, recent results, and its use for targeted cell-based therapy.
An invited talk in the Precision Medicine: Data and Discovery for Improved Health and Therapy Session
Jennifer Doudna, Li Ka Shing Chancellor's Chair in Biomedical and Health Sciences
Howard Hughes Medical Institute Investigator, and Professor, Molecular & Cell Biology; Professor, Chemistry at UC Berkeley

[@sent4dc]

So if I understood correctly they can cut out chunks of RNA but they cannot add them yet. Is that right?

[@appleifc]

WOW!

[@gwangwadaniel]

This technique is very awrsum scientific break thought but i have a lot of question and ethical problem with it because if its going to be authorized to human application companies which will be using it can edit human embryo to do a lot of genetic changes that get get out of control in the future.This will produce a new generation of genetic modified human which can facilitate a man made human evolution.Again who is gonna authorize which genes should be edited and on what condition and another thing is money ,only rich people will be able to edit their genes and they wont die or get sick .

[@obaidullahkhan797]

but still we don't know about our DNA so lts still ambitous.So we still cannot apply it to people.

[@angelomartan7762]

Why so hurry to speak, are you trying to impress us about your speed reading, dpeaking?

[@KevinP32270]

FREAKING AMAZING!!!

[@hasanaiham9070]

😢😮